Drugs / LTM1201AD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03858751 | Mar 2019 → Nov 2022 overdue | obstructive sleep apnea syndrome | Brigham and Women's Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LTM1201AD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03858751 ↗ |
| Route | Oral | “LTM1201AD oral capsule before sleep” NCT03858751 ↗ |